Wyss InstituteMicrofluidics – Wyss Institute

David Chou on keeping people safe from radiation on Earth and beyond

Jessica Leff — Thu, 28 May 2026 13:00:27 +0000

The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. David Chou’s work is literally out of this world! In addition to identifying radiation countermeasures for use on Earth, he is part of the AVATAR project, which aims to understand how humans…

Source

Multidisciplinary Wyss team receives 2026 Lush Prize Science Award

Jessica Leff — Mon, 18 May 2026 18:30:48 +0000

(BOSTON) — The Wyss Institute for Biologically Inspired Engineering at Harvard University is proud to announce that the Biosensing, Microfluidics, and Microsystems team, led by Wyss Senior Engineer Adama Sesay, Ph.D., together with the Female Reproductive Health team, has received the 2026 Lush Science Prize. The prize recognizes their work developing next-generation, sensor-integrated human Organ…

Source

Wyss Institute technologies enable breakthrough in astronaut health research aboard NASA’s Artemis II mission

Jessica Leff — Thu, 09 Apr 2026 14:55:20 +0000

By Alexandra Jirstrand (BOSTON) – Launched on April 1, 2026, Artemis II is a historic, approximately 10-day lunar flyby mission that is sending four astronauts farther into space than any humans have traveled since the Apollo era, marking a critical step toward sustained lunar exploration and future missions to Mars. The Wyss Institute for Biologically Inspired Engineering at Harvard…

Source

AVATARs for Astronaut Health Are Heading to Space!

Jessica Leff — Thu, 05 Feb 2026 15:04:20 +0000

NASA’s AVATAR experiment is flying aboard Artemis II to study how deep space affects human health. Using Organ Chips containing astronaut cells, Emulate and Wyss Institute researchers will examine how radiation and microgravity impact human tissue. This research will help inform medical strategies for future long-duration missions to Mars and beyond. The findings could also contribute to…

Source

Transforming cancer treatments through bioinspired engineering and translation

Jessica Leff — Wed, 04 Feb 2026 14:59:03 +0000

Despite major advances in personalized medicine, targeted drugs, and immunotherapies, many cancers remain difficult – or impossible – to treat. Even when therapies work, they can trigger serious secondary health risks that may themselves become life-threatening. Wyss Institute researchers are tackling these challenges head-on by developing new therapies that more powerfully activate the immune…

Source

Organs on Chips: Using Science, Art, and Design to Understand the Human Body – Talking About Blood

Jessica Leff — Thu, 20 Nov 2025 18:41:34 +0000

In this episode, Wyss Founding Director Don Ingber, M.D., Ph.D., talks with Helen Osborne about: How organ-on-chip and “human body on chips” technologies are built and how they realistically mimic human organ function by combining living cells, blood flow, and mechanical forces like breathing and stretch; The implications of these chips for hematology and clinical care…

Source

Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies

Jessica Leff — Wed, 15 Oct 2025 13:55:54 +0000

By Benjamin Boettner (BOSTON) – The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that, despite seasonally updated vaccines, IAV infections still lead to 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths annually. The development of antiviral treatments against IAV…

Source

Wyss Institute receives Wellcome Leap funding to develop first Human Organ Chip model for heavy menstrual bleeding

Jessica Leff — Fri, 19 Sep 2025 13:55:11 +0000

By Alexandra Jirstrand (BOSTON) – The Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded funding from Wellcome Leap’s $50 million The Missed Vital Sign program, which seeks to transform how menstruation is understood and treated in healthcare. The Wyss will use its pioneering Organ Chip technology to create the first human model of heavy menstrual…

Source

Human cervix modeled in microfluidic organ chip fills key women’s health gap

Jessica Leff — Fri, 31 May 2024 14:55:29 +0000

By Benjamin Boettner (BOSTON) — Bacterial Vaginosis (BV) has been identified as one of the many unmet needs in women’s health and affects more than 25% of reproductive-aged women. It is caused by pathogenic bacteria that push the healthy microbiomes in the female vagina and cervix – the small gatekeeper canal that connects the uteruns and vagina – into a state of imbalance known as dysbiosis.

Source

Mice Don’t Menstruate: Reimagining Women’s Health Using Organ Chips with Dr. Donald Ingber

Jessica Leff — Wed, 08 May 2024 13:05:03 +0000

In this episode, host Sharon Kedar, Co-Founder of Northpond Ventures, is joined by Dr. Donald Ingber, Founding Director at Wyss Institute for Biologically Inspired Engineering at Harvard University. Dr. Ingber’s commitment to following his passion has led him to countless medical and technological breakthroughs, including Organ Chip technology. These incredible chips recreate the structure and…

Source